We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-1.81%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.56B
AUM Growth
+$94.2M
Cap. Flow
+$293M
Cap. Flow %
5.28%
Top 10 Hldgs %
35.79%
Holding
4,002
New
390
Increased
2,050
Reduced
771
Closed
169
Avg Time Held Equity + Options
4.8 years
Top 10 Avg Time Held Equity + Options
3.5 years
Top 20 Avg Time Held Equity + Options
4.4 years
Avg Time Held Equity only
4.8 years
Top 10 Avg Time Held Equity only
3.5 years
Top 20 Avg Time Held Equity only
4.4 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BYND icon
3776
Beyond Meat
BYND
$119M
$27 ﹤0.01%
+1
New +$24
2026 Q1
0 quarters
HYLN icon
3777
Hyliion Holdings
HYLN
$570M
$25 ﹤0.01%
14
– –
2020 Q3
22 quarters
ORGN icon
3778
DELISTED
Origin Materials
ORGN
$25 ﹤0.01%
11
– –
2021 Q2
19 quarters
ECF icon
3779
Ellsworth Growth & Income Fund
ECF
$159M
$24 ﹤0.01%
2
– –
2021 Q1
20 quarters
OPENW icon
3780
Opendoor Technologies Inc Series K Warrants
OPENW
$1.93M
$23 ﹤0.01%
38
-2
-5% -$2
2025 Q4
1 quarter
SCLX icon
3781
Scilex Holding
SCLX
$19.6M
$20 ﹤0.01%
3
– –
2025 Q2
3 quarters
CTRM icon
3782
Castor Maritime
CTRM
$16.1M
$19 ﹤0.01%
10
– –
2025 Q2
3 quarters
GME.WS icon
3783
GameStop Corp Warrants
GME.WS
$19 ﹤0.01%
5
+1
+25% +$4
2025 Q4
1 quarter
RNAC icon
3784
Cartesian Therapeutics
RNAC
$202M
$18 ﹤0.01%
103
– –
2020 Q4
21 quarters
UPB icon
3785
Upstream Bio Inc
UPB
$184M
$18 ﹤0.01%
2
– –
2025 Q2
3 quarters
AGEN icon
3786
Agenus
AGEN
$312M
$17 ﹤0.01%
5
– –
2025 Q2
3 quarters
AVTX icon
3787
Avalo Therapeutics
AVTX
$658M
$15 ﹤0.01%
1
– –
2020 Q1
24 quarters
ONL icon
3788
Orion Office REIT
ONL
$122M
$13 ﹤0.01%
6
– –
2022 Q1
16 quarters
TLX icon
3789
Telix Pharmaceuticals
TLX
$3.59B
$13 ﹤0.01%
1
-11
-92% -$84
2025 Q4
1 quarter
DCTH icon
3790
Delcath Systems
DCTH
$516M
$9 ﹤0.01%
1
– –
2020 Q2
23 quarters
LILAK icon
3791
Liberty Latin America Class C
LILAK
$1.6B
$9 ﹤0.01%
+1
New +$7
2026 Q1
0 quarters
OPENL icon
3792
Opendoor Technologies Inc Series A Warrants
OPENL
$2.4M
$9 ﹤0.01%
38
-2
-5% -$1
2025 Q4
1 quarter
OPENZ icon
3793
Opendoor Technologies Inc Series Z Warrants
OPENZ
$2.02M
$9 ﹤0.01%
38
-2
-5% -$1
2025 Q4
1 quarter
WKHS icon
3794
Workhorse Group
WKHS
$31.6M
$3 ﹤0.01%
1
– –
2025 Q2
3 quarters
CCO icon
3795
Clear Channel Outdoor Holdings
CCO
$1.23B
$2 ﹤0.01%
1
– –
2023 Q2
11 quarters
IMUX icon
3796
Immunic
IMUX
$94.1M
– –
0
– –
2018 Q2
31 quarters
XXII
3797
22nd Century Group
XXII
$457K
– –
0
– –
2018 Q2
31 quarters
YYAI icon
3798
AiRWA Inc
YYAI
$3.31M
– –
0
– –
2026 Q1
0 quarters
ABM icon
3799
ABM Industries
ABM
$3.03B
– –
-13
Closed -$550 –
ACVA icon
3800
ACV Auctions
ACVA
$1.78B
– –
-1,376
Closed -$11K –

Similar funds

Parallel Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Parallel Advisors held 4,002 positions worth $5.56B, up 1.7% from $5.47B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors deployed $293M of net new capital in Q1 2026, opening 390 new positions and adding to 2,050 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 48% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $180M trimmed.

  • Parallel Advisors's largest Q1 2026 buy was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $160M increase.
  • Parallel Advisors's biggest Q1 2026 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $180M.
  • Parallel Advisors fully exited iShares 1-3 Year International Treasury Bond ETF in Q1 2026, selling an estimated $741K.
  • Parallel Advisors's ten largest holdings make up 36% of its $5.56B portfolio in Q1 2026.
  • Parallel Advisors opened 390 new positions and closed 169 in Q1 2026.
  • Parallel Advisors's portfolio value rose 1.7% quarter-over-quarter to $5.56B.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.